Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer. (Q41835248)
Jump to navigation
Jump to search
scientific article published on 26 May 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer. |
scientific article published on 26 May 2016 |
Statements
Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer (English)
Yvette Drew
Jonathan Ledermann
Geoff Hall
Daniel Rea
Ros Glasspool
Martin Highley
Gordon Jayson
Julieann Sludden
James Murray
Sarah Halford
Gary Acton
Zoe Backholer
Raffaella Mangano
1 reference